Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...
Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating ERLEADA® without docetaxel ...
Florida Cancer Specialists & Research Institute, LLC (FCS) is among the first oncology providers in Florida selected to ...
Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...
News-Medical.Net on MSN
Oxybutynin shows promise in managing hot flashes for prostate cancer patients
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
6d
Laser therapy eradicates prostate cancer in 84% of patients – without ‘causing erectile dysfunction’
A CUTTING-EDGE cold laser therapy could effectively treat prostate cancer and slash the risk of any debilitating side effects. Australian researchers discovered that the new treatment could ...
An Italian oncologic psychologist warns these patients: “A prostatectomy doesn’t cure anxiety.” Emotional distress can be so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results